Having low lung function as a middle-aged smoker without airway obstruction raised the likelihood for all-cause mortality, ...

The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.

The FDA has approved Jascayd (nerandomilast) as a treatment for a second lung disease, progressive pulmonary fibrosis, following the drug’s initial approval in October 2025 as a treatment for ...

Please provide your email address to receive an email when new articles are posted on . A smartphone-based tool that employs acoustic sensing and machine learning techniques is set to undergo testing.

The use of inhaled corticosteroids during pregnancy may protect against reduced lung function in infants born to mothers with ...

Just two months after reviving its prowess in the idiopathic pulmonary fibrosis (IPF) treatment area with rare lung disease med Jascayd, Boehringer Ingelheim is already unlocking another patient po | ...

Pulmonary diagnostic tests are a series of tests which evaluate how well the lungs are performing. These tests may be performed to help diagnose disease, monitor disease progression or therapeutic ...

New research has identified the mechanism by which air pollution damages the lungs’ self-cleaning system, leaving us vulnerable to infection. In doing so, it has also identified a way to reverse that ...

A Brazilian study involving nearly 900 participants under the age of 40 reinforces the idea that premature lung aging is ...

COPD is hiding in plain sight. Once lung function is lost, it is largely irretrievable. That makes neglect more costly ...